耳鼻咽喉科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 耳鼻咽喉科威廉亚洲博彩公司

2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 ：季节性过敏性鼻炎的治疗(更新版)

2017-11-02 美国过敏、哮喘和免疫学会 Ann Allergy Asthma Immunol. 2017 Nov 2.

过敏性鼻炎的治疗

2017年11月，美国过敏、哮喘和免疫学会(AAAAI)、美国过敏、哮喘与免疫学院(ACAAI)以及过敏、哮喘和免疫联合委员会(JCAAI)共同更新发布了季节性过敏性鼻炎的治疗威廉亚洲博彩公司 。该威廉亚洲博彩公司 是对2008年版威廉亚洲博彩公司 的更新，主要内容涉及季节性过敏性鼻炎的治疗。

中文标题：

2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 ：季节性过敏性鼻炎的治疗(更新版)

英文标题：

Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update.

发布机构：

美国过敏、哮喘和免疫学会

发布日期：

2017-11-02

简要介绍：

2017年11月，美国过敏、哮喘和免疫学会(AAAAI)、美国过敏、哮喘与免疫学院(ACAAI)以及过敏、哮喘和免疫联合委员会(JCAAI)共同更新发布了季节性过敏性鼻炎的治疗威廉亚洲博彩公司 。该威廉亚洲博彩公司 是对2008年版威廉亚洲博彩公司 的更新，主要内容涉及季节性过敏性鼻炎的治疗。

 

拓展威廉亚洲博彩公司 ：与鼻炎相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 ：季节性过敏性鼻炎的治疗(更新版))] GetToolGuiderByIdResponse(projectId=1, id=21c3a1c00152257d, title=2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 ：季节性过敏性鼻炎的治疗(更新版), enTitle=Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update., guiderFrom=Ann Allergy Asthma Immunol. 2017 Nov 2., authorId=null, author=, summary=2017年11月，美国过敏、哮喘和免疫学会(AAAAI)、美国过敏、哮喘与免疫学院(ACAAI)以及过敏、哮喘和免疫联合委员会(JCAAI)共同更新发布了季节性过敏性鼻炎的治疗威廉亚洲博彩公司 。该威廉亚洲博彩公司 是对2008年版威廉亚洲博彩公司 的更新，主要内容涉及季节性过敏性鼻炎的治疗。 , cover=, journalId=null, articlesId=null, associationId=568, associationName=美国过敏、哮喘和免疫学会, associationIntro=美国过敏、哮喘和免疫学会（AAAAI）是一个专业组织，有美国，加拿大和其他72个国家的6500多名成员，包括过敏/免疫学家，及致力于过敏性和免疫性疾病的研究和治疗相关专业医护人员。, copyright=0, guiderPublishedTime=Thu Nov 02 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年11月，美国过敏、哮喘和免疫学会(AAAAI)、美国过敏、哮喘与免疫学院(ACAAI)以及过敏、哮喘和免疫联合委员会(JCAAI)共同更新发布了季节性过敏性鼻炎的治疗威廉亚洲博彩公司 。该威廉亚洲博彩公司 是对2008年版威廉亚洲博彩公司 的更新，主要内容涉及季节性过敏性鼻炎的治疗。 </P> <P> </P>拓展威廉亚洲博彩公司 ：<strong>与<font color=red>鼻炎</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=8cbc61c001a29ec6" title="2017 EAACI意见书：非过敏性鼻炎" target=_blank>2017 EAACI意见书：非过敏性鼻炎</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=b927b1c0013953ca" title="儿童普通感冒与变应性鼻炎早期识别和诊治专家共识" target=_blank>儿童普通感冒与变应性鼻炎早期识别和诊治专家共识</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=939941c00139111c" title="【威廉亚洲博彩公司 专题】变应性鼻炎如何诊断与治疗？答案在这里！" target=_blank>【威廉亚洲博彩公司 专题】变应性鼻炎如何诊断与治疗？答案在这里！</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=ab8491c00136ead0" title="2017 JSA威廉亚洲博彩公司 ：过敏性鼻炎" target=_blank>2017 JSA威廉亚洲博彩公司 ：过敏性鼻炎</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=ce8c81c001220502" title="变应性鼻炎诊断和治疗威廉亚洲博彩公司 （2015年，天津）" target=_blank>变应性鼻炎诊断和治疗威廉亚洲博彩公司 （2015年，天津）</a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E9%BC%BB%E7%82%8E" target=_blank>有关鼻炎更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=64002, tagName=过敏性鼻炎的治疗)], categoryList=[CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8635, appHits=622, showAppHits=0, pcHits=5724, showPcHits=3604, likes=132, shares=18, comments=8, approvalStatus=1, publishedTime=Tue Nov 21 22:27:54 CST 2017, publishedTimeString=2017-11-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Nov 21 22:27:54 CST 2017, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 20:06:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 ：季节性过敏性鼻炎的治疗(更新版))])
2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 ：季节性过敏性鼻炎的治疗(更新版)
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010004, encodeId=a49e1010004b3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sat Aug 21 13:12:59 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962942, encodeId=421f96294221, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210505/633c6f14bd8f4c6cafcae40cfc8c1a3f/0ced4bbbfabf4bbfa6a0ef0373d45a5f.jpg, createdBy=4cc15492906, createdName=huiyan, createdTime=Wed May 05 23:22:03 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908044, encodeId=04a090804485, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5fb5444552, createdName=ms1000002015121000, createdTime=Tue Dec 15 04:28:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297131, encodeId=822029e13191, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffaf2287040, createdName=121da432m13暂无昵称, createdTime=Sat Mar 17 15:18:45 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271530, encodeId=57fe2e1530f9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/c9349b9bcd901b026bd750f7335f78f1.jpg, createdBy=13b02179645, createdName=曾超军, createdTime=Fri Dec 22 12:56:45 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2021-08-21 18薛定谔的猫81

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010004, encodeId=a49e1010004b3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sat Aug 21 13:12:59 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962942, encodeId=421f96294221, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210505/633c6f14bd8f4c6cafcae40cfc8c1a3f/0ced4bbbfabf4bbfa6a0ef0373d45a5f.jpg, createdBy=4cc15492906, createdName=huiyan, createdTime=Wed May 05 23:22:03 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908044, encodeId=04a090804485, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5fb5444552, createdName=ms1000002015121000, createdTime=Tue Dec 15 04:28:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297131, encodeId=822029e13191, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffaf2287040, createdName=121da432m13暂无昵称, createdTime=Sat Mar 17 15:18:45 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271530, encodeId=57fe2e1530f9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/c9349b9bcd901b026bd750f7335f78f1.jpg, createdBy=13b02179645, createdName=曾超军, createdTime=Fri Dec 22 12:56:45 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2021-05-05 huiyan

    赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010004, encodeId=a49e1010004b3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sat Aug 21 13:12:59 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962942, encodeId=421f96294221, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210505/633c6f14bd8f4c6cafcae40cfc8c1a3f/0ced4bbbfabf4bbfa6a0ef0373d45a5f.jpg, createdBy=4cc15492906, createdName=huiyan, createdTime=Wed May 05 23:22:03 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908044, encodeId=04a090804485, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5fb5444552, createdName=ms1000002015121000, createdTime=Tue Dec 15 04:28:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297131, encodeId=822029e13191, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffaf2287040, createdName=121da432m13暂无昵称, createdTime=Sat Mar 17 15:18:45 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271530, encodeId=57fe2e1530f9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/c9349b9bcd901b026bd750f7335f78f1.jpg, createdBy=13b02179645, createdName=曾超军, createdTime=Fri Dec 22 12:56:45 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2020-12-15 ms1000002015121000

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010004, encodeId=a49e1010004b3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sat Aug 21 13:12:59 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962942, encodeId=421f96294221, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210505/633c6f14bd8f4c6cafcae40cfc8c1a3f/0ced4bbbfabf4bbfa6a0ef0373d45a5f.jpg, createdBy=4cc15492906, createdName=huiyan, createdTime=Wed May 05 23:22:03 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908044, encodeId=04a090804485, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5fb5444552, createdName=ms1000002015121000, createdTime=Tue Dec 15 04:28:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297131, encodeId=822029e13191, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffaf2287040, createdName=121da432m13暂无昵称, createdTime=Sat Mar 17 15:18:45 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271530, encodeId=57fe2e1530f9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/c9349b9bcd901b026bd750f7335f78f1.jpg, createdBy=13b02179645, createdName=曾超军, createdTime=Fri Dec 22 12:56:45 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2018-03-17 121da432m13暂无昵称

    棒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1010004, encodeId=a49e1010004b3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sat Aug 21 13:12:59 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962942, encodeId=421f96294221, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210505/633c6f14bd8f4c6cafcae40cfc8c1a3f/0ced4bbbfabf4bbfa6a0ef0373d45a5f.jpg, createdBy=4cc15492906, createdName=huiyan, createdTime=Wed May 05 23:22:03 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908044, encodeId=04a090804485, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5fb5444552, createdName=ms1000002015121000, createdTime=Tue Dec 15 04:28:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297131, encodeId=822029e13191, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffaf2287040, createdName=121da432m13暂无昵称, createdTime=Sat Mar 17 15:18:45 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271530, encodeId=57fe2e1530f9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/c9349b9bcd901b026bd750f7335f78f1.jpg, createdBy=13b02179645, createdName=曾超军, createdTime=Fri Dec 22 12:56:45 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-22 曾超军

    不错

    0